Uncategorized

Our faculty impact communities and the pipeline, but also individual patients with medical conditions that are difficult to treat and require unique expertise. Dr. Elizabeth[...]

Dr. Christina Charles-Schoeman, chief of rheumatology, recently published important findings from the FDA mandated post authorization, safety end-point trial, ORAL Surveillance, examining risk of major[...]